Melody Y. Li
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Developmental dysfunction in a preclinical model of Kcnq2 developmental and epileptic encephalopathy.
Journal: Neurobiology of disease
Published: June 29, 2024
Variant-specific in vitro neuronal network phenotypes and drug sensitivity in SCN2A developmental and epileptic encephalopathy.
Journal: Journal of neurochemistry
Published: September 02, 2023
Carbogen-Induced Respiratory Acidosis Blocks Experimental Seizures by a Direct and Specific Inhibition of NaV1.2 Channels in the Axon Initial Segment of Pyramidal Neurons.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: July 18, 2022
Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model.
Journal: The Journal of clinical investigation
Published: June 07, 2021
Protective effects of medium chain triglyceride diet in a mouse model of Dravet syndrome.
Journal: Epilepsia
Published: March 25, 2021
Antisense oligonucleotide therapy for KCNT1 encephalopathy.
Journal: JCI insight
Published: December 01, 2020
Functional consequences of the CAPOS mutation E818K of Na+,K+-ATPase.
Journal: The Journal of biological chemistry
Published: June 29, 2018
Lack of response to quinidine in KCNT1-related neonatal epilepsy.
Journal: Epilepsia
Published: March 30, 2018
Gabapentin Modulates HCN4 Channel Voltage-Dependence.
Journal: Frontiers in pharmacology
Published: May 30, 2017
Precision therapy for epilepsy due to KCNT1 mutations: A randomized trial of oral quinidine.
Journal: Neurology
Published: May 21, 2017
Last Updated: 09/26/2026